Rebus Holdings, Inc. (RBSH)

USD 0.0

(0.0%)

Market Cap (In USD)

3213.00

Revenue (In USD)

-

Net Income (In USD)

-1.02 Million

Avg. Volume

796.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.01
PE
-
EPS
-
Beta Value
1.445
ISIN
US75619J1034
CUSIP
75619J103
CIK
1421204
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Raul Silvestre Esq.
Employee Count
-
Website
https://www.rebus-corp.com
Ipo Date
2009-11-04
Details
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.